Published in Biol Psychiatry on October 01, 2006
Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry (2010) 4.27
Prevalence estimates of combat-related post-traumatic stress disorder: critical review. Aust N Z J Psychiatry (2010) 1.75
Neurobiological sequelae of witnessing stressful events in adult mice. Biol Psychiatry (2012) 1.17
Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder. Stress (2008) 1.10
Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors. J Psychiatr Res (2009) 0.86
Ten-year follow-up study of PTSD diagnosis, symptom severity and psychosocial indices in aging holocaust survivors. Acta Psychiatr Scand (2008) 0.82
Changes in brain anatomy during the course of posttraumatic stress disorder. Psychiatry Res (2011) 0.80
Pattern of cognitive impairment in older veterans with posttraumatic stress disorder evaluated at a memory disorders clinic. Int J Geriatr Psychiatry (2011) 0.80
Mood symptoms contribute to working memory decrement in active-duty soldiers being treated for posttraumatic stress disorder. Brain Behav (2012) 0.79
Influence of acute psychological trauma on time estimation behaviour: a prospective pilot study. J Neural Transm (Vienna) (2012) 0.76
Cognitive impairment among World Trade Center responders: Long-term implications of re-experiencing the 9/11 terrorist attacks. Alzheimers Dement (Amst) (2016) 0.75
Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science (2010) 12.39
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 3.57
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry (2006) 2.95
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry (2010) 2.35
The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11
Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab (2005) 1.96
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res (2010) 1.91
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry (2009) 1.85
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res (2009) 1.66
Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59
Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 1.57
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 1.55
Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res (2007) 1.55
Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr Bull (2009) 1.54
Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry (2012) 1.53
Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. OMICS (2014) 1.49
Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophr Res (2006) 1.47
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
PeakRanger: a cloud-enabled peak caller for ChIP-seq data. BMC Bioinformatics (2011) 1.44
Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. Am J Psychiatry (2008) 1.44
Fully automatic segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm. J Magn Reson Imaging (2008) 1.41
Assessing everyday functioning in schizophrenia: not all informants seem equally informative. Schizophr Res (2011) 1.37
Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry (2004) 1.34
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res (2008) 1.30
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord (2009) 1.28
Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study. J Int Neuropsychol Soc (2008) 1.26
The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol (2006) 1.24
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull (2003) 1.24
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophr Bull (2008) 1.21
Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disord (2010) 1.19
Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol (2006) 1.17
Memory performance in older trauma survivors: implications for the longitudinal course of PTSD. Ann N Y Acad Sci (2006) 1.14
Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology (2010) 1.13
Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology (2004) 1.12
Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia. Schizophr Res (2012) 1.12
The ACTH response to dexamethasone in PTSD. Am J Psychiatry (2004) 1.12
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am J Psychiatry (2002) 1.12
Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol (2004) 1.12
Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophr Res (2011) 1.11
Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat (2006) 1.11
Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers (2011) 1.11
Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change. Schizophr Res (2010) 1.09
Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord (2012) 1.08
Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition. Am J Med Genet B Neuropsychiatr Genet (2007) 1.07
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol (2008) 1.07
Circadian rhythm of salivary cortisol in Holocaust survivors with and without PTSD. Am J Psychiatry (2005) 1.05
Premorbid functioning and treatment response in recent-onset schizophrenia. Br J Psychiatry (2006) 1.04
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study. Schizophr Res (2006) 1.04
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother (2012) 1.04
Memory performance in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (2002) 1.02
The effects of child abuse and neglect on cognitive functioning in adulthood. J Psychiatr Res (2012) 1.01
Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable? Anesthesiology (2007) 1.00
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology (2013) 1.00
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. Am J Psychiatry (2002) 1.00
Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res (2011) 1.00
Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res (2006) 0.99
Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophr Res (2008) 0.99
Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. Am J Geriatr Psychiatry (2012) 0.98
The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry (2002) 0.97
Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology (2005) 0.97
Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests. Schizophr Res (2007) 0.96
Relationship between cortisol and age-related memory impairments in Holocaust survivors with PTSD. Psychoneuroendocrinology (2005) 0.96
Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness. Early Interv Psychiatry (2013) 0.95
The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry (2006) 0.95
Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophr Res (2013) 0.95
Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosci (2008) 0.93
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. Schizophr Res (2004) 0.93
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res (2007) 0.93
Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophr Bull (2005) 0.93
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92